Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Bluepoint Laboratories for the product Acetaminophen (NDC 68001-495). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each extended release tablet), purpose, uses, warnings, do not use, stop use and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Acetaminophen USP 650 mg
Pain reliever/fever reducer
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
whether a drug contains acetaminophen, ask a doctor or pharmacist.
Ask a doctor before ue if you have liver disease.
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right
away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you
do not notice any signs or symptoms.
do not take more than directed (see overdose warning).
Adults:
Under 18 years of age:
colloidal silicon dioxide, hydroxyethyl cellulose, hypromellose, magnesium stearate, microcrystalline
cellulose, povidone, pregelatinized starch (maize), sodium starch glycolate, titanium dioxide, triacetin
call 1-855-274-4122
Manufactured by:
Aurobindo Pharma Limited
Unit-VII (SEZ), Mahabubnagar (Dt)-509302, India.
For BluePoint Laboratories
Rev: 03/2021
M.L. No.: 22/MN/AP/2009/F/R
Acetaminophen Extended-Release tablets USP 650mg (100 tablets Carton) NDC: 68001-495-00
Acetaminophen Extended-Release tablets USP 650mg (100 tablets Container Label) NDC: 68001-495-00
* Please review the disclaimer below.